SCYNEXIS, Inc. (SCYX)

USD 0.92

(4.61%)

Operating Expenses Summary of SCYNEXIS, Inc.

  • SCYNEXIS, Inc.'s latest annual operating expenses in 2023 was 51.84 Million USD , down -43.43% from previous year.
  • SCYNEXIS, Inc.'s latest quarterly operating expenses in 2024 Q1 was 10.88 Million USD , down -22.55% from previous quarter.
  • SCYNEXIS, Inc. reported a annual operating expenses of 90.22 Million USD in annual operating expenses 2022, up 22.46% from previous year.
  • SCYNEXIS, Inc. reported a annual operating expenses of 73.67 Million USD in annual operating expenses 2021, up 44.99% from previous year.
  • SCYNEXIS, Inc. reported a quarterly operating expenses of 9.97 Million USD for 2024 Q2, down -8.34% from previous quarter.
  • SCYNEXIS, Inc. reported a quarterly operating expenses of 14.51 Million USD for 2023 Q2, up 24.32% from previous quarter.

Annual Operating Expenses Chart of SCYNEXIS, Inc. (2023 - 2012)

Historical Annual Operating Expenses of SCYNEXIS, Inc. (2023 - 2012)

Year Operating Expenses Operating Expenses Growth
2023 51.84 Million USD -43.43%
2022 90.22 Million USD 22.46%
2021 73.67 Million USD 44.99%
2020 50.81 Million USD 3.62%
2019 49.04 Million USD 62.18%
2018 30.24 Million USD 13.78%
2017 26.57 Million USD -5.33%
2016 28.07 Million USD -1.86%
2015 28.6 Million USD 79.88%
2014 15.9 Million USD 81.87%
2013 8.74 Million USD -36.03%
2012 13.66 Million USD 0.0%

Peer Operating Expenses Comparison of SCYNEXIS, Inc.

Name Operating Expenses Operating Expenses Difference
Bright Green Corporation 8.25 Million USD -528.242%
Alpha Teknova, Inc. 45.85 Million USD -13.06%
ANI Pharmaceuticals, Inc. 195.98 Million USD 73.545%
Aquestive Therapeutics, Inc. 44.85 Million USD -15.593%
Collegium Pharmaceutical, Inc. 159.2 Million USD 67.434%
Cosmos Health Inc. 26.18 Million USD -98.038%
Journey Medical Corporation 54.59 Million USD 5.03%
Embecta Corp. 528.4 Million USD 90.188%
Esperion Therapeutics, Inc. 271.89 Million USD 80.931%
Dynavax Technologies Corporation 219.14 Million USD 76.341%
Intra-Cellular Therapies, Inc. 590 Million USD 91.212%
Pacira BioSciences, Inc. 326.37 Million USD 84.114%
PainReform Ltd. 9.58 Million USD -440.985%
Sunshine Biopharma, Inc. 13.12 Million USD -295.048%
Sunshine Biopharma, Inc. 13.12 Million USD -295.048%
Safety Shot Inc 12.1 Million USD -328.153%
China SXT Pharmaceuticals, Inc. 3.06 Million USD -1589.307%
Procaps Group, S.A. 199.47 Million USD 74.008%
Theratechnologies Inc. 72.75 Million USD 28.737%
Harrow Health, Inc. 89.97 Million USD 42.374%
Sonoma Pharmaceuticals, Inc. 9.44 Million USD -448.888%
Biofrontera Inc. 39.95 Million USD -29.753%
DURECT Corporation 43.71 Million USD -18.605%
Supernus Pharmaceuticals, Inc. 529.01 Million USD 90.199%
Cronos Group Inc. 96.7 Million USD 46.388%
OptiNose, Inc. 85.1 Million USD 39.075%
Ironwood Pharmaceuticals, Inc. 232.12 Million USD 77.664%
Kala Pharmaceuticals, Inc. 39.15 Million USD -32.424%
RedHill Biopharma Ltd. -9.56 Million USD 642.286%
Organogenesis Holdings Inc. 314.13 Million USD 83.495%
Guardion Health Sciences, Inc. 9.73 Million USD -432.822%
Cumberland Pharmaceuticals Inc. 43.04 Million USD -20.463%
Radius Health, Inc. 265.92 Million USD 80.503%
Universe Pharmaceuticals INC 13.84 Million USD -274.573%
ProPhase Labs, Inc. 37.85 Million USD -36.976%
Phibro Animal Health Corporation 260.29 Million USD 80.081%
Procaps Group S.A. 187.24 Million USD 72.31%
Alvotech 285.43 Million USD 81.836%
TherapeuticsMD, Inc. 9.82 Million USD -427.715%
Viatris Inc. 5.96 Billion USD 99.131%
Rockwell Medical, Inc. 15.37 Million USD -237.245%
Aytu BioPharma, Inc. 59.84 Million USD 13.356%
SIGA Technologies, Inc. 22.04 Million USD -135.213%
Tilray Brands, Inc. 251.35 Million USD 79.373%
Lifecore Biomedical, Inc. 49.03 Million USD -5.73%
Shineco, Inc. 17.94 Million USD -188.878%
PetIQ, Inc. 192.72 Million USD 73.097%
Regencell Bioscience Holdings Limited 3.99 Million USD -1199.078%
Incannex Healthcare Limited 30.05 Million USD -72.522%
Neurocrine Biosciences, Inc. 1.59 Billion USD 96.752%
Alimera Sciences, Inc. 62.64 Million USD 17.23%
Silver Spike Investment Corp. 762.49 Thousand USD -6699.809%
Assertio Holdings, Inc. 368.58 Million USD 85.933%
Shuttle Pharmaceuticals Holdings, Inc. 5.88 Million USD -780.934%
Petros Pharmaceuticals, Inc. 17.8 Million USD -191.141%
Clever Leaves Holdings Inc. 21.16 Million USD -144.924%
Cyclo Therapeutics, Inc. 21.04 Million USD -146.401%
Avadel Pharmaceuticals plc 164.96 Million USD 68.57%
Hempacco Co., Inc. 7.59 Million USD -582.529%
Talphera, Inc. 11.99 Million USD -332.283%
Alvotech 285.43 Million USD 81.836%
Eagle Pharmaceuticals, Inc. 140.71 Million USD 63.154%
Lantheus Holdings, Inc. 344.9 Million USD 84.967%
Currenc Group, Inc. 24 Million USD -116.015%
Kamada Ltd. 45.42 Million USD -14.137%
Indivior PLC 911 Million USD 94.309%
Evoke Pharma, Inc. 12.4 Million USD -317.804%
Flora Growth Corp. 10.57 Million USD -390.103%
Cyclo Therapeutics, Inc. 21.04 Million USD -146.401%
Evolus, Inc. 189.75 Million USD 72.677%
HUTCHMED (China) Limited 436.23 Million USD 88.115%
Amphastar Pharmaceuticals, Inc. 154.13 Million USD 66.362%
Akanda Corp. 3.48 Million USD -1388.385%